Stay updated on Ibrutinib and Nivolumab Trial in Hodgkin Lymphoma

Sign up to get notified when there's something new on the Ibrutinib and Nivolumab Trial in Hodgkin Lymphoma page.
Latest website image capture
Clouds background image

Latest updates to the Ibrutinib and Nivolumab Trial in Hodgkin Lymphoma page

  1. Check
    yesterday
    Change Detected
    Summary
    Recruitment status 'No longer looking for participants' is displayed on the study details page, and new help/navigation sections 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study' have been added. The Intervention/Treatment header is updated, and the revision tag now shows v3.6.0, replacing the previous v3.5.5.
    Difference
    0.5%
    Check dated 2026-06-14T06:21:41.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The page revision stamp was updated to v3.5.5, replacing the previous v3.5.4. This appears to be a backend or CMS update rather than a change to study information or features.
    Difference
    0.1%
    Check dated 2026-06-07T03:11:22.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    No Change Detected
  5. Check
    29 days ago
    Change Detected
    Summary
    The revision label has been updated from v3.5.3 to v3.5.4, signaling a system update. This change does not alter the study content or its presented details.
    Difference
    0.1%
    Check dated 2026-05-16T09:25:24.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    ClinicalTrials.gov updated the page’s revision/build indicator from v3.5.2 to v3.5.3, reflecting a site version change rather than any changes to the study record.
    Difference
    0.1%
    Check dated 2026-04-24T22:23:42.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T13:59:10.000Z thumbnail image
  8. Check
    87 days ago
    Change Detected
    Summary
    Site revision history shows an addition of v3.5.0 and a deletion of v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T23:30:45.000Z thumbnail image

Stay in the know with updates to Ibrutinib and Nivolumab Trial in Hodgkin Lymphoma

Enter your email address, and we'll notify you when there's something new on the Ibrutinib and Nivolumab Trial in Hodgkin Lymphoma page.